Correlation Between Nuvectis Pharma and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Eliem Therapeutics, you can compare the effects of market volatilities on Nuvectis Pharma and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Eliem Therapeutics.
Diversification Opportunities for Nuvectis Pharma and Eliem Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nuvectis and Eliem is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Eliem Therapeutics
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 43.0 times less return on investment than Eliem Therapeutics. But when comparing it to its historical volatility, Nuvectis Pharma is 1.19 times less risky than Eliem Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 251.00 in Eliem Therapeutics on September 2, 2024 and sell it today you would earn a total of 53.00 from holding Eliem Therapeutics or generate 21.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.19% |
| Values | Daily Returns |
Nuvectis Pharma vs. Eliem Therapeutics
Performance |
| Timeline |
| Nuvectis Pharma |
| Eliem Therapeutics |
Nuvectis Pharma and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Eliem Therapeutics
The main advantage of trading using opposite Nuvectis Pharma and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |